Picard-Willems B - Search Results

1

Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.

Bluecher A, Meyer Dos Santos S, Ferreirós N, Labocha S, Meyer Dos Santos IM, Picard-Willems B, Harder S, Singer OC. Bluecher A, et al. Among authors: picard willems b. Thromb Haemost. 2017 Feb 28;117(3):519-528. doi: 10.1160/TH16-08-0619. Epub 2017 Jan 26. Thromb Haemost. 2017. PMID: 28124061

2

Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications.

Harder S, Parisius J, Picard-Willems B. Harder S, et al. Among authors: picard willems b. Thromb Res. 2008;123(2):396-403. doi: 10.1016/j.thromres.2008.05.010. Epub 2008 Jun 24. Thromb Res. 2008. PMID: 18571698

3

Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.

Graff J, Picard-Willems B, Harder S. Graff J, et al. Among authors: picard willems b. Int J Clin Pharmacol Ther. 2007 Apr;45(4):237-43. doi: 10.5414/cpp45237. Int J Clin Pharmacol Ther. 2007. PMID: 17474542

4

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants.

Meyer Dos Santos S, Zorn A, Guttenberg Z, Picard-Willems B, Kläffling C, Nelson K, Klinkhardt U, Harder S. Meyer Dos Santos S, et al. Among authors: picard willems b. Biomicrofluidics. 2013 Oct 4;7(5):56502. doi: 10.1063/1.4824043. eCollection 2013. Biomicrofluidics. 2013. PMID: 24404078 Free PMC article.

5

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow.

Meyer dos Santos S, Kuczka K, Picard-Willems B, Nelson K, Klinkhardt U, Harder S. Meyer dos Santos S, et al. Among authors: picard willems b. Platelets. 2015;26(1):59-66. doi: 10.3109/09537104.2013.870332. Epub 2014 Jan 16. Platelets. 2015. PMID: 24433287 Free article.

6

Long term administration of LMWH - pharmacodynamic parameters under therapeutic or prophylactic regimen of enoxaparin or tinzaparin in neurological rehabilitation patients.

Kuczka K, Baum K, Picard-Willems B, Harder S. Kuczka K, et al. Among authors: picard willems b. Thromb Res. 2009 Nov;124(5):625-30. doi: 10.1016/j.thromres.2009.06.017. Epub 2009 Jul 21. Thromb Res. 2009. PMID: 19625075

7

CXCL16/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium.

Linke B, Meyer Dos Santos S, Picard-Willems B, Keese M, Harder S, Geisslinger G, Scholich K. Linke B, et al. Among authors: picard willems b. Cytokine. 2019 Oct;122:154081. doi: 10.1016/j.cyto.2017.06.008. Epub 2017 Jun 21. Cytokine. 2019. PMID: 28647282

8

Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.

Kuczka K, Harder S, Picard-Willems B, Warnke A, Donath F, Bianchini P, Parma B, Blume H. Kuczka K, et al. Among authors: picard willems b. J Clin Pharmacol. 2008 Oct;48(10):1189-96. doi: 10.1177/0091270008322911. Epub 2008 Aug 20. J Clin Pharmacol. 2008. PMID: 18716314 Clinical Trial.

9

Activated Platelets Induce an Anti-Inflammatory Response of Monocytes/Macrophages through Cross-Regulation of PGE₂ and Cytokines.

Linke B, Schreiber Y, Picard-Willems B, Slattery P, Nüsing RM, Harder S, Geisslinger G, Scholich K. Linke B, et al. Among authors: picard willems b. Mediators Inflamm. 2017;2017:1463216. doi: 10.1155/2017/1463216. Epub 2017 May 16. Mediators Inflamm. 2017. PMID: 28592915 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters